Talphera (TLPH) Change in Account Payables (2010 - 2026)
Talphera (TLPH) recorded quarterly Change in Account Payables of $210000.0 in Q1 2026, up 125.81% quarter-over-quarter from $93000.0 in Q4 2025, and up 160.87% on a YoY basis from $80500.0 in Q1 2025.
Talphera (TLPH) Change in Account Payables (2010 - 2026) Analysis & Trends
Talphera's Change in Account Payables history runs 17 years deep, the most recent figure standing at $210000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 160.87% year-over-year to $210000.0; the TTM figure through Mar 2026 stood at $347000.0 (up 136.37% YoY), while the FY2025 annual figure was -$208000.0, up 69.0% from the prior year.
- Change in Account Payables was $210000.0 for Q1 2026 at Talphera, up from $93000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $526000.0 in Q4 2022 to a low of -$774000.0 in Q2 2023.
- Historically, Change in Account Payables has averaged -$40764.7 across 5 years, with a median of $37000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables jumped 409.41% in 2022, then slumped 2191.89% in 2023.
- A 5-year view of Change in Account Payables shows it stood at $526000.0 in 2022, then retreated by 27.38% to $382000.0 in 2023, then retreated by 28.27% to $274000.0 in 2024, then tumbled by 66.06% to $93000.0 in 2025, then jumped by 125.81% to $210000.0 in 2026.
- The last three Change in Account Payables figures came in at $210000.0 (Q1 2026), $93000.0 (Q4 2025), and -$466000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 190,000.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 562,000.00 |
| 10 | Talphera | 61.00 Mn | 61.00 Mn | - | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Dec 31, 2023 | 382,000.00 |
| Dec 31, 2023 | 382,000.00 |